UBS Group
TOKE

UBS Group’s Cambria Cannabis ETF TOKE Stock Holding History

UBS Group’s Portfolio TOKE Stock Details TOKE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-461
Closed -$6K – 10713
2021
Q3 		$6K Buy
+461
New +$7.24K ﹤0.01% 8452
2020
Q4 		– Sell
-596
Closed -$7K – 8765
2020
Q3 		$7K Sell
596
-1,006
-63% -$12.3K ﹤0.01% 7146
2020
Q2 		$20K Sell
1,602
-196
-11% -$2.3K ﹤0.01% 6565
2020
Q1 		$19K Buy
+1,798
New +$23.7K ﹤0.01% 6537

Other funds holding TOKE

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CA
Cambridge Advisors Omaha, Nebraska $582M AUM 19.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
TC
TAP Consulting Kirkwood, Missouri $489M AUM 8.88% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
PFA
Professional Financial Advisors North Platte, Nebraska $578M AUM 19.5% 1-Year Est. Return

UBS Group's TOKE Position: Q4 2021 in Review

UBS Group sold out of Cambria Cannabis ETF (TOKE) in Q4 2021, closing a stake of 461 shares — an estimated $6K sold.

UBS Group first reported a position in TOKE in Q1 2020 and held it in 4 quarters. The position peaked at $20K in Q2 2020. 26 funds tracked by Wall St. Rank hold TOKE as of Q4 2021.

  • UBS Group reported no remaining Cambria Cannabis ETF position as of Q4 2021 after selling out during the quarter.
  • UBS Group sold 461 Cambria Cannabis ETF shares in Q4 2021, an estimated $6K.
  • UBS Group first reported a position in Cambria Cannabis ETF in Q1 2020 and held it in 4 quarters.
  • UBS Group's Cambria Cannabis ETF position peaked at $20K in Q2 2020.
  • 26 funds tracked by Wall St. Rank held Cambria Cannabis ETF as of Q4 2021.

Based on UBS Group's 13F filing for Q4 2021, filed 14 Feb 2022.